273 participants
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-02
- Start Date:
- 2018-03-07
- Completion:
- 2020-11-13
Conditions
- Metastatic Triple Negative Breast Cancer
Interventions
- DRUG